212 related articles for article (PubMed ID: 15251985)
21. Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis.
Ghesquières H; Berger F; Felman P; Callet-Bauchu E; Bryon PA; Traverse-Glehen A; Thieblemont C; Baseggio L; Michallet AS; Coiffier B; Salles G
J Clin Oncol; 2006 Nov; 24(33):5234-41. PubMed ID: 17043351
[TBL] [Abstract][Full Text] [Related]
22. B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations.
Stohl W; Metyas S; Tan SM; Cheema GS; Oamar B; Xu D; Roschke V; Wu Y; Baker KP; Hilbert DM
Arthritis Rheum; 2003 Dec; 48(12):3475-86. PubMed ID: 14673998
[TBL] [Abstract][Full Text] [Related]
23. A role for BLyS in the activation of innate immune cells.
Chang SK; Arendt BK; Darce JR; Wu X; Jelinek DF
Blood; 2006 Oct; 108(8):2687-94. PubMed ID: 16825497
[TBL] [Abstract][Full Text] [Related]
24. Role of BAFF/BAFF-R axis in B-cell non-Hodgkin lymphoma.
Yang S; Li JY; Xu W
Crit Rev Oncol Hematol; 2014 Aug; 91(2):113-22. PubMed ID: 24629840
[TBL] [Abstract][Full Text] [Related]
25. Nuclear CD40 interacts with c-Rel and enhances proliferation in aggressive B-cell lymphoma.
Zhou HJ; Pham LV; Tamayo AT; Lin-Lee YC; Fu L; Yoshimura LC; Ford RJ
Blood; 2007 Sep; 110(6):2121-7. PubMed ID: 17567982
[TBL] [Abstract][Full Text] [Related]
26. Mutational analysis of human BLyS in patients with common variable immunodeficiency.
Losi CG; Salzer U; Gatta R; Lougaris V; Cattaneo G; Meini A; Soresina A; Grimbacher B; Plebani A
J Clin Immunol; 2006 Jul; 26(4):396-9. PubMed ID: 16838132
[TBL] [Abstract][Full Text] [Related]
27. Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome.
Lavie F; Miceli-Richard C; Quillard J; Roux S; Leclerc P; Mariette X
J Pathol; 2004 Apr; 202(4):496-502. PubMed ID: 15095277
[TBL] [Abstract][Full Text] [Related]
28. B-lymphocyte stimulator (BLyS) stimulates immunoglobulin production and malignant B-cell growth in Waldenstrom macroglobulinemia.
Elsawa SF; Novak AJ; Grote DM; Ziesmer SC; Witzig TE; Kyle RA; Dillon SR; Harder B; Gross JA; Ansell SM
Blood; 2006 Apr; 107(7):2882-8. PubMed ID: 16304043
[TBL] [Abstract][Full Text] [Related]
29. Rapid and specific targeting of 125I-labeled B lymphocyte stimulator to lymphoid tissues and B cell tumors in mice.
Riccobene TA; Miceli RC; Lincoln C; Knight Y; Meadows J; Stabin MG; Sung C
J Nucl Med; 2003 Mar; 44(3):422-33. PubMed ID: 12621010
[TBL] [Abstract][Full Text] [Related]
30. BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2.
Kayagaki N; Yan M; Seshasayee D; Wang H; Lee W; French DM; Grewal IS; Cochran AG; Gordon NC; Yin J; Starovasnik MA; Dixit VM
Immunity; 2002 Oct; 17(4):515-24. PubMed ID: 12387744
[TBL] [Abstract][Full Text] [Related]
31. Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity.
Yan M; Marsters SA; Grewal IS; Wang H; Ashkenazi A; Dixit VM
Nat Immunol; 2000 Jul; 1(1):37-41. PubMed ID: 10881172
[TBL] [Abstract][Full Text] [Related]
32. Human B lymphocyte malignancies: exploitation of BLyS and APRIL and their receptors.
Jelinek DF; Darce JR
Curr Dir Autoimmun; 2005; 8():266-88. PubMed ID: 15564725
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and release of B-lymphocyte stimulator from myeloid cells.
Nardelli B; Belvedere O; Roschke V; Moore PA; Olsen HS; Migone TS; Sosnovtseva S; Carrell JA; Feng P; Giri JG; Hilbert DM
Blood; 2001 Jan; 97(1):198-204. PubMed ID: 11133761
[TBL] [Abstract][Full Text] [Related]
34. BAFF-R is expressed on B-cell lymphomas depending on their origin, and is related to proliferation index of nodal diffuse large B-cell lymphomas.
Takahata H; Ohara N; Ichimura K; Tanaka T; Sato Y; Morito T; Takata K; Kojima M; Kobata T; Yoshino T
J Clin Exp Hematop; 2010; 50(2):121-7. PubMed ID: 21123970
[TBL] [Abstract][Full Text] [Related]
35. BAFF/BLyS receptor 3 comprises a minimal TNF receptor-like module that encodes a highly focused ligand-binding site.
Gordon NC; Pan B; Hymowitz SG; Yin J; Kelley RF; Cochran AG; Yan M; Dixit VM; Fairbrother WJ; Starovasnik MA
Biochemistry; 2003 May; 42(20):5977-83. PubMed ID: 12755599
[TBL] [Abstract][Full Text] [Related]
36. Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen.
Schneider P; Takatsuka H; Wilson A; Mackay F; Tardivel A; Lens S; Cachero TG; Finke D; Beermann F; Tschopp J
J Exp Med; 2001 Dec; 194(11):1691-7. PubMed ID: 11733583
[TBL] [Abstract][Full Text] [Related]
37. BAFF supports human B cell differentiation in the lymphoid follicles through distinct receptors.
Zhang X; Park CS; Yoon SO; Li L; Hsu YM; Ambrose C; Choi YS
Int Immunol; 2005 Jun; 17(6):779-88. PubMed ID: 15908449
[TBL] [Abstract][Full Text] [Related]
38. Critical evaluation of Bcl-6 protein expression in diffuse large B-cell lymphoma of the stomach and small intestine.
Kwon MS; Go JH; Choi JS; Lee SS; Ko YH; Rhee JC; Ree HJ
Am J Surg Pathol; 2003 Jun; 27(6):790-8. PubMed ID: 12766583
[TBL] [Abstract][Full Text] [Related]
39. BAFF/BLyS can potentiate B-cell selection with the B-cell coreceptor complex.
Hase H; Kanno Y; Kojima M; Hasegawa K; Sakurai D; Kojima H; Tsuchiya N; Tokunaga K; Masawa N; Azuma M; Okumura K; Kobata T
Blood; 2004 Mar; 103(6):2257-65. PubMed ID: 14630796
[TBL] [Abstract][Full Text] [Related]
40. Plasma levels of B-lymphocyte stimulator increase with HIV disease progression.
Rodriguez B; Valdez H; Freimuth W; Butler T; Asaad R; Lederman MM
AIDS; 2003 Sep; 17(13):1983-5. PubMed ID: 12960832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]